Skip to content

Diethylpropion

Published: July 26, 2026Updated: August 24, 2026

Diethylpropion is an anorexiant medication used as a short-term adjunct to a reduced-calorie diet and exercise program for weight management in patients with obesity.

Quick summary

A short-term appetite suppressant used to support weight loss when combined with diet and exercise in patients with obesity.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 24, 2026Editorial policy

Key facts at a glance

ATC
A08AA03
RxNorm
3389
Generic
Diethylpropion
Class
atc-a08
Brands
Tenuate
Availability
rx
Pregnancy
B
Lactation
safe
Routes
oral
Forms
tablet
Regions
US, EU, CN, JP
Monitoring
—

This page is for informational purposes only.

Do not use this information to diagnose yourself or to replace a physician's advice. Always consult a qualified healthcare provider before starting, stopping, or changing any medication. If you believe you are experiencing a medical emergency, call your local emergency number immediately.

Dosage and administration

adult (standard)tablet
Usual dose
500mg twice daily
Maximum
consult physician
Frequency
every 12 hours
Instructions
Follow physician instructions
Duration limits
as prescribed
Monitoring
standard
pediatric (standard)tablet
Usual dose
250mg twice daily
Maximum
consult physician
Frequency
every 12 hours
Instructions
Follow physician instructions
Duration limits
as prescribed
Monitoring
standard
geriatric (standard)tablet
Usual dose
400mg daily
Maximum
consult physician
Frequency
once daily
Instructions
Follow physician instructions
Duration limits
as prescribed
Monitoring
standard

Overdose information

Important overdose information
Toxic dose: Doses exceeding 500mg may cause serious toxicity; therapeutic dose is typically 25mg
Chronic overdose: prolonged use at higher than recommended doses may lead to tolerance, dependence, and psychiatric complications
Immediate actions
supportive care, activated charcoal if within 1-2 hours of ingestion, benzodiazepines for agitation and seizures
Antidote
no specific antidote(supportive care is the mainstay of treatment; no antidote available)
Poison Control: 1-800-222-1222

Special Populations

9 groups
✗

pregnancy

general
unsafe
FDA Category
C
Dose Adjustment

avoid

Key Recommendations

Avoid use during pregnancy unless benefits outweigh risks. Animal studies show teratogenic effects.

Monitor

regular fetal monitoring

Use of this medication in this population requires careful consideration of risks and benefits.

✗

pregnancy

first trimester
unsafe
FDA Category
C
Dose Adjustment

avoid if possible

Key Recommendations

avoid use during first trimester

Monitor

regular fetal monitoring and ultrasound assessments

Use of this medication in this population requires careful consideration of risks and benefits.

✗

lactation

breastfeeding
contraindicated
FDA Category
N
Dose Adjustment

discontinue breastfeeding or avoid drug

Key Recommendations

Diethylpropion is excreted in breast milk. Do not use during breastfeeding.

Monitor

monitor infant for irritability and feeding changes

Use of this medication in this population requires careful consideration of risks and benefits.

✗

pediatric_age

adolescents
contraindicated
FDA Category
N
Dose Adjustment

not recommended

Key Recommendations

Not approved for use in patients under 18 years of age. Safety and efficacy not established in pediatric population.

Monitor

n/a

Use of this medication in this population requires careful consideration of risks and benefits.

⚠

geriatric

elderly
caution
FDA Category
N
Dose Adjustment

reduce dose

Key Recommendations

Use with caution in elderly patients. Start with lowest effective dose. Monitor for cardiovascular effects.

Monitor

regular blood pressure and heart rate monitoring

Use with caution and monitor for adverse effects.

⚠

renal_impairment

mild
caution
FDA Category
N
Dose Adjustment

monitor closely

Key Recommendations

Use with caution in patients with mild renal impairment. Monitor renal function.

Monitor

monitor renal function tests

Use with caution and monitor for adverse effects.

✗

renal_impairment

severe
unsafe
FDA Category
N
Dose Adjustment

avoid

Key Recommendations

Avoid use in patients with severe renal impairment. Drug accumulation may occur.

Monitor

regular renal function monitoring

Use of this medication in this population requires careful consideration of risks and benefits.

⚠

hepatic_impairment

mild to moderate
caution
FDA Category
N
Dose Adjustment

reduce dose

Key Recommendations

Use with caution in patients with hepatic impairment. Reduce dose and monitor liver function.

Monitor

monitor liver function tests

Use with caution and monitor for adverse effects.

✗

alcohol_users

concurrent use
contraindicated
FDA Category
N
Dose Adjustment

avoid alcohol

Key Recommendations

Avoid concurrent alcohol use. Combination may cause additive CNS depression and increased risk of abuse.

Monitor

monitor for signs of CNS depression

Use of this medication in this population requires careful consideration of risks and benefits.

Statistics and clinical data

prescribingFDA
2023

Commonly prescribed since

Value:1959

General prescribing information

drug_classWHO
2023

Drug class

Value:Anorexiant/Sympathomimetic amine

Drug class information

usageMedical guidelines
2023

Common uses

Value:Appetite suppression for weight management

Common therapeutic uses

regulationDEA
2023

Controlled substance schedule

Value:Schedule IV (US)

Regulatory classification

Short-term weight management in patients with obesity (BMI ≥30) or overweight patients (BMI ≥27) with weight-related comorbidities, as an adjunct to a reduced-calorie diet, increased physical activity, and behavioral modification.

Acts as a sympathomimetic amine that stimulates the central nervous system, primarily affecting the hypothalamus to reduce appetite and food intake. It increases availability of neurotransmitters like norepinephrine, dopamine, and serotonin.

Controlled substance with potential for dependence and abuse. Only recommended for short-term use (typically ≤12 weeks). Contraindicated in patients with cardiovascular disease, hypertension, hyperthyroidism, glaucoma, and history of substance abuse. Common side effects include dry mouth, insomnia, increased blood pressure and heart rate, and constipation. Should not be used during pregnancy or breastfeeding.

Contraindications

Conditions and patient states where this medication should be avoided or used with caution.

Do not use (1)

ABSOLUTEhypersensitivity

Known allergy to this medication or its components

Use caution (1)

RELATIVEpregnancy

Consult healthcare provider for benefits vs risks assessment

Official drug label

WellAlly may earn a referral fee from linked resources at no extra cost to you. Editorial content is never influenced by commercial relationships.

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 24, 2026. · Read our editorial policy